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The catalytic subunit of type-l protein phosphatase (PPl) was phosphorylated by the tyrosine kinase v-abl as follows: (i) cytosolic PPI was 
phosphorylated more (0.73 molImo1) than PPI obtained from the glycogcn particles (0.076 mol/mol), while free catalytic subunit isolated in the 
active or inactive form from cytosolic PPI was phosphorylated even lass and catalytic subunit complexed with inhibitor-2 was not phosphorylated; 
(ii) phosphorylation stoichiometry was dependent on the concentration of PPI and 3 h incubation at 30°C was required for maximal phosphoryl- 
ation; (iii) phosphorylation was on a tyrosine residue located in the C-terminal region of PPI which is lost during proteolysis; (iv) pb2sphorylation 
did not affect enzyme activity but allowed conversion from the active to the inactive form upon incubation with inhibitor-2 of a PPl form that 
in its dephospho-form did not convert. 
Protein phosphatase; Protein kinase; Tyrosine kinase; Phosphorylation 
1. INTRODUCTION 
Phosphatases that dephosphorylate protein at serine/ 
threonine residues (PP) are involved in metabolic regu- 
lations, such as activation of glycogen and fatty acid 
synthesis and regulation of contractile proteins (see [I ] 
for review), as well as in the regulation of cell prolifera- 
tion (see [2] for review). PP of type-l (PPl), the most 
abundant PP in many cells and tissues [1], is activated 
by hormones and growth factors (e.g. insulin [3-51 and 
EGF [6]) and during the cell cycle [2,7]. PPl is regulated 
through covalent modifications of its regulatory subu- 
nits: inhibitor-2 (12) in the cytosol is a target for the 
kinases FAIGSK3 and casein kinase II [8-l 1] that acti- 
vate PPl; the G-subunit in the glycogen particles is a 
target for an insulin-stimulated kinase [12] that activates 
PPI, and for protein kinase A, through which adrena- 
line inhibits PPl (reviewed in [I]). The PPl catalytic 
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ase assayed here as phosphorylase phosphatase; PPI, protein phos- 
phatase of type-l; E, catalytic subunit of PPI; E,, active E; E,“, 
cytosolic E, purified by a procedure that includes ethanol precipita- 
tion; E,‘, catalytic subunit ofPP1 purified from the glycogen particles; 
Ei, inactive E isolated from the 70 kDa E,-12 cytosolic complex; EaMn, 
obtained from E, following activation by Mn2’. EIIFA, E, isolated from 
the 70 kDa cytosolic complex that had been activated by the kinasc 
FJGSK3; 12, inhibitor-2 of PPl; F,/GSK3, protein kinase that acti- 
vates PPI, also called glycogcn synthase kinase-3. 
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subunit exists in various active and inactive conforma- 
tions [SJ that may be obtained as free catalytic subunits 
or bound to the regulatory subunits. Some years ago it 
was reported that PPl might be also regulated by direct 
phosphorylation of the catalytic subunit by the tyrosine 
kinases v-src or c-src [13]. Phosphorylation, which was 
in a trypsin-sensitive r gion of PPI, was up to 0.34 
mol/mol and induced a parallel decrease in enzyme ac- 
tivity [13,14]. Preliminary data also suggested that the 
v-abl tyrosine kinase was able to phosphorylate the PPl 
catalytic subunit [14,15]. Here we report that cytosolic 
PPl purified as active catalytic subunit is indeed a sub- 
strate for the v-abl tyrosine kinase and that phosphoryl- 
ation facilitates its inactivation by I2 in diluted condi- 
tions. 
2. MATERIALS AND METHODS 
2. I. Marerials 
TPCK-treated trypsill. soybean trypsin inhibitor, ATP, BSA, 
PMSF, benzamidine, TPCK, poly(Glu/ryr) (4: I), Freund adjuvants 
phosphotyrosine, bovine IgG, molecular weight markers, peroxidase 
conjugated anti-guinea pig JgG, bovine JgG and Keyhole Limpets 
hemocyanin were purchased from Sigma. [“PIPi was from Du Pont. 
Peroxidase conjugated anti-rabbit IgG, Hyperfilms-MP and Hyper- 
films-ECL and ECL were from Amersham. Affi-Gel 10 and thechemi- 
cals for elcctrophoresis and transblot were from Bio-Rad, The FPLC 
system and the SI column were from Pharmacia. Opti Phase II scintil- 
lant was from LKB. 
PP was assayed by the release of ‘zPi from [“2P]phosphorylasc (I (2-4 
x 10’ cpm/pmol) with or without trypsin treatment (2O,~ug/ml trypsin 
for 5 min at 30°C followed by 120 @ml soybean trypsin inhibitor) 
in the presence or not of0.5 mM MnC12 [8], in 5Oyl final volume [5,8]. 
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The tyrosine kinase activity of v-abl was assayed with the substrate 
poly(Glflyr) (4: I) co-polymer at 2 mg/ml. final concentration, in the 
presence of 0.5 mM ATP, [“PJATP (100-200 cpm/pmol). 20 mM 
imidazolc. pH 7.5, 3% glycerol, 50 mM NaCI, 12 mM MgCI,, 4 mM 
MnC&, 0.2 mM EGTA, 0.05% Triton X-IGiJ, 0.2 mM orthovanadate. 
After ICI min at 30°C the reaction mixture was applied to Whatman 
P-81 chromatography paper. After 4 washes in 10 mM H,PO,, P-81 
paper was dryed and counted in Opti Phase II scintillant. 
2.3. Enzyme md protein prtrificotions 
Inactive 70 kDa cytosolic PPI [16], cytosolic E,” [l7], glycogen 
particle EaG [l8], I2 and phosphorylase b were purified from rabbit 
skeletal muscle IS]. Ei. EilMn and EaFA were isolated by SI ion exchange 
chromatography at pH S.0 on FPLC from cytosolic 70 kDa PPI. as 
previously described [8]. The trypsin-treatment to produce the 33 kDa 
form from the various 37 kDa E, was performed at 20pg/mI trypsin 
for IO min at 3O”C, followed by 120 pglml soybean trypsin inhibitor 
[8]. Muscle phosphorylase kinase was a gift from Dr. L.M.G. Heil- 
meyer (Ruhuniversitlt-Bochum, Germany). Rabbit muscle phospho- 
rylase b was used to produce “P-labeled phospborylase a 1181. 
[“P]ATP (2000 CiImmol) was prepared using inorganic [“P]phosphatc 
as described [I8]. v-abl was isolated [ 191 from E. co/i expressing recom- 
binant v-abl [20], concentrated on Amicon Centricon, and stored at 
-70°C in the presence of 50% glycerol. The final preparation had a 
spec. act. of IS.3 nmol/mg using poly(Glumyr) (4: I) as substrate and 
was not contaminated by scrine/threonine kinase since neither phos- 
phoserine nor pbosphothreonine were detected in myelin basic protein 
phosphorylated by v-abl (E.V.-M., S. Lapi, G. Gaudino and P.M. 
Comoglio. in preparation). Protein was determined by the method of 
Bradford [2l], using BSA as standard. 
2.4. Phosphorylation of PPI 
The incubation (50 ,ul) contained 0. I mM ATP. I2 mM M7’Yz, 4 
mM MnCI,, 0.2 mM EGTA. 0.1 mM sodium orthovanadate, 50 mM 
NaCl and 4-5 x IO’ cpm/pmol p’P]ATP. the amount of v-abl that 
would incorporate 46 pmoles of “P into poly(Glu/Tyr) (4:l) per min 
at 30°C (see above) and PPI as specifically indicated. After 8 h at 
30°C. unless indicated otherwise. the reaction was stopped by the 
addition of 8 ~1 0. I % deoxycholate and 9~1 50% trichloroacetic acid. 
After IO min on ice the samples were centrifuged at 4°C for 5 min in 
a Micro&e E, the pcllct was resuspended in 12 ~1 electrophoresis 
sample buffer for subsequent electrophorcsis [22] and autoradiog- 
raphy on Hyperfilms-MP. 
2.5. Pepridc s.wrhesis rend prohcriort of (ttui-PPI crtttibodiies 
A I6 amino acid-long peptide reproducing the sequence from resi- 
due 294-309 of PPla [23] was carried out essentially according to 
Merrifield [24] with an Applied Biosystems model 430 Automatic 
Peptide Synthetizcr. The synthetic pcptidc was cleaved from the solid 
support and side chain protective groups were removed by treatment 
with anhydrous hydrofluoric acid 125). I .5 mg of crude peptide bound 
to 1.5 mg of Keyhole Limpet Hemocyanin. as previously described 
[26], was mixed with complctc Freund adjuvanr 2nd injected into a 
rabbit [26]. Anti-PPI catalytic subunit antibodies wcrc detected by 
both ELISA and Western blot using PPI as antigen. 
2.6. Production of atrti.plrosillror~rositle attrihodies 
4.8 mg of phosphotyrosinc bound to 4.6 mg bovine IgG was injected 
into 3 guinea pigs as previously described [26]. Dctcction of positivity 
in scra was done by ELISA using phosphotyrosinc bound IO ovalbu- 
mine as antigen [26]. Antibodies were purified by afftnity chromatog- 
raphy on a column prepared with I.5 ml Afli-Gel IO and 5 mg phos- 
photyrosinc [26]. 
2.7. Dtrttr~orohlorrittg 
After clectrophorcsis 1221 on a 10% polyacrylamidc gel in a Mini- 
Protean Bio-Had apparatus and Wcstcrn blot onto tlitroccllulosc [27]. 
PPI catalytic subunit was dctcctcd with 5 ~1 of anti-PPI strum, and 
proteins phosphorylatcd on tyrosinc wcrc dctcctcd with 2-3 ~6 of 
affinity purified anti-phosphotyrosine IgG. Pcroxidase-con,jugated 
anti-IgG. ECL reagents and Hyperfilms-ECL were used for immuno- 
detection. 
3. RESULTS AND DISCUSSION 
To investigate whether recombinant v-abl tyrosine 
kinase phosphorylates the catalytic subunit of PPl we 
used the active catalytic subunits E,” obtained from 
cytosol [ 171 or EaG from glycogen particles [ 181, or inac- 
tive cytosolic 70 kDa complex (consisting of inactive 
catalytic subunit Ei and 12 [16]). We found that v-abl 
phosphorylated E,” (Figs. lc and 2A) more efficiently 
than EaG (Figs. la and 2A), while Ei bound to I2 in the 
70 kDa complex purified from cytosol (Fig. le) or E,” 
in a complex reconstituted from E,” and I2 (not shown) 
was not phosphorylated. Failure to phosphorylate the 
70 kDa E-12, either as purified or as reconstituted com- 
plex, may be due to the association with I2 that prevents 
access to the phosphorylation site (as suggested also for 
src phosphorylation [13]) or, alternatively, to the en- 
zyme conformation (see below). 
The stoichiometry of v-abl phosphorylation depen- 
ded on the concentration of E,” (Fig. 2A). Up to 0.73 
mol/mol Pi was introduced into E;,” at 18 nM while EaG 
was phosphorylated only up to 0.076 mol/mol. Phos- 
phorylation of E,” was relatively slow and reached its 
maximum in about 3 h (Fig. 2B). This is similar to that 
reported for v-src or c-src phosphorylation of cytosolic 
El, [13,14], although in the latter case phosphorylation 
was only up to 0.34 mol/mol [13]. The fact that high 
stoichiometry was obtained only at high E;, dilution 
migh! be explained by assuming a high affinity between 
v-abi Snase and E;,, with the consequence that dissocia- 
tion of the enzyme-product complex is obtained only at 
high dilution. This mechanism or, alternatively, the 
presence of some inhibitory component in the PPI pre- 
paration, would explain also the marked inhibition of 
v-abl autophosphorylation that we detected at the 
highest E;,” or E;,” concentrations (not shown). 
Limited tryptic proteolysis reduces the SDS-electro- 
phoresis size of cytosolic E;, forms [ 161 and of E,’ [ 181 
from 37 kDa to 33 kDa. The 33 kDa E;, obtained from 
both E,” and EilG could no longer be phosphorylated by 
v-abl (Fig. lb and d), indicating that the phosphoryla- 
tion site was located in the =4 kDa fragment removed 
by proteolysis. Based on the size of the proteolyzed E, 
and assuming that trypsin removes about 30 residues 
from the C-terminus [I]. we raised antibodies to a 16- 
amino acid peptide reproducing the sequence of PPlcl 
from residue 294-309 [23]. These antibodies recognized 
the 37 kDa (Fig. lg) but not the 33 kDa proteolyzed E,,” 
(Fig. lh) confirming that the ==4 kDa fragment removed 
by trypsin was from the C-terminus. Phosphorylation 
was confirmed to be on tyrosine since anti-phosphoty- 
rosine antibodies recognized the v-abl-phosphorylatcd 
E,” in Western blot (Fig. 11). whercns they did not 
68 
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Fig. I. Phosphorylation of various PPI fowls by recombinant v-abl tyrosine kinase. (a) 1 /!g of catalytic subunit from glycogen particles (E,o) in 
native 37 kDa. (b) proteolyzed 33 kDa form of E;,o, (c) 1 flu$ of cytosolic catalytic subunit (E;,e’) in native 37 kDa (d) proteolyzed 33 kDa form 
of Ej;‘. (e) I .6pg cytosolic 70 kDa PPI (37 kDa catalytic subunit E,-inhibitor 2 complex) and(f) buffer only. were phosphorylated with v-abl tyrosine 
kinase in the presence of [“‘PIATP for 8 h at 30°C and subjected to SDS-electrophoresis on a 10% polyacrylamide gel followed by autoradiography. 
The procedure to obtain the proteolyzcd 33 kDa form is described in section 2. (d) and (f) show also the upper part of a heavily phosphorylated 
30 kDa band present in the v-abl preparation. whose degree of phosphorylation varies in the presence of the various PPI samples. 
Detection of PPI catalytic subunit on Western blot with anti-PPI peptide antibodies. (g) 125 ng of E,” in native 37 kDa: (h) proteolyzed 33 kDa 
form; (i) 200 ng of 37 kDa E,“. 
Detection of PPI catalytic subunit on Western blot with anti-phosphotyrosinc antibodies. (1.m) 125 ng, (t) 280 ng of 37 kDa E;,“. (n) SO0 ng of 
proteolyzcd 33 kDa E,“. (0) 850 ng of 37 kDa EaG. (p.r) 280 ng of Ei (inactive catalytic subunit), (s) 280 ng of E;,“” (E, activated by Mn”) and 
(q.u) 280 ng of E:,“’ (E, isolated from 70 kDa PPl complex after activation by F,,/GSK3). phosphorylated (I,n.r-u) or not (m.0.p.q) with v-abl 
in the presence of unlabeled ATP for 8 h at 30°C. The ~45 kDa and ==55 kDa bands in lanes I,n. r-u are the 2 autophosphorylated v-abl products. 
Standard proteins: 116 kDa. /?-galactosidase; 68 kDa, BSA: 43 kDa. ovalbumin: 35 kDa. PPI catalytic subunit. 
recognize unphosphorylated E,” (Fig. lm), indicating 
the absence of endogenous phospho-tyrosine. Also the 
proteolyzed 33 kDa E,“’ was not recognized by the anti- 
phosphotyrosine antibodies (Fig. In), thus confirming 
that the phosphorylation site was in the trypsin-sensi- 
tive region. 
Low phosphorylation of E,” was neither due to phos- 
phorylation site occupancy, since anti-phosphotyrosine 
antibodies did not recognize EtiG in Western blot (Fig, 
lo). nor to absence of the trypsin-sensitive region, since 
E;,” was recognized by the anti-IV1 antibodies (Fig. Ii). 
The possibility that some G bound to E;, might prevent 
phosphorylation, similar to that described for I2 (see 
[I 3-l 51 and above), was also discarded since E;,” had 
been obtained by a puri!ication procedure that removes 
G [18], and in fact no G was detected in the E,,” prepa- 
ration by anti-G antibodies [2G] in Western blot (not 
shown). Consequently the results seem to indicate that 
the different level of phosphorylation between E,” and 
EaG may be due to different conformations or possibly 
to different isozymes (see also [8]). 
To further investigate the effect of E conformation on 
phosphorylation by v-abl we tested various E forms, all 
of them isolated from the 70 kDa cytosolic PPI by SI 
chromatography on FPLC [8]. Ei was obtained directly 
from the inactive 70 kDa PPl. EoMn was obtained by 
activating Ei with Mn” and Eo”* was obtained from 70 
kDa PPl that had been activated by FJGSK3. None 
of these E forms were recognized by anti-phosphotyro- 
sine antibodies before incubating with v-abl (see e.g. Ei 
and E,“” in Fig. 1 p and q). After v-abl phosphorylation 
still none of these forms was recognized by the antibod- 
ies (Fig. Ir,s and u) in an experiment where E,” was 
phosphorylated, as expected (Fig. 1 t), Phosphorylation 
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Fig, 2, Phosphorylation f the 37 kDa E~ =' (e) or E. ° {&) by the v-abl 
tyrosine kinase. (A) PPI was phosphorylated for 8 h at 30°C in the 
presence of [~:P]ATP at the indicated final concentrations and then 
subjected to SDS-electrophoresis and autoradiography. The 37 kDa 
protein bands were excised from the gel, mixed with scintillant and 
counted. (B) En ct (18 nM, final concentration) was phosphorylated at
30°C for the time indicated as described in (A). Stoichiometry was 
calculated assuming phosphorylation atone site. 
of E f  A was also attempted atvarious Ea concentrations 
in the presence of [3:P]ATP and the highest stoichiome- 
try obtained was 0.05 mol/mol at 18 nM E~ (compare 
with Fig, 2A). 
Phosphorylation did not affect the activity of Ea et or 
E~ c towards phosphorylase a in up to 8 h incubation at 
30°C (not shown). In this respect v-abl phosphorylation 
was different from src phosphorylation, which was ac- 
companied by a parallel decrease in enzyme activity 
[13-15]. We have no explanation for such a discrepancy, 
since the phosphorylation site seems to be the same as 
well as the substrate for PPI assay. However, we found 
that phosphorylation byv-abl influenced the interaction 
of E~ ~' with I2, When Ea et was incubated in diluted 
conditions (36 nM) with 10-fold excess I2 the activity 
was inhibited by approximately 75% (compare basal 
activity and activity after trypsin at time 0 in Fig, 3A), 
We have shown previously [8,16] that trypsin-treatment 
removes 12 allowing the assay of E~. Upon incubation 
in the presence of I2, E,, slowly converts to the inactive 
E~ conformation, which needs Mn a÷ for activation. Con- 
version is revealed by the loss of reactivation with tryp- 
sin alone (activity is recovered with trypsin and Mn:+), 
We found that when we used Ea et it did not convert o 
2O ~ B 
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Fig. 3. Conversion of the 37 kDa Ef t from active to inactive form. E, =t 
phosphorylatcd (Cand D) or not (A and B) with v-abl in the presence 
of" unlabeled ATP was incubated at the final concentration of 36 nM 
with (A and C) or without (B and D) 350 nM inhibitor-2. At each time 
point aliquots were taken from the incubation mixture to assay PPI 
for basal activity (o) or following activation with trypsin (A) or trypsin 
and Mn z• (m). 
E~, as indicated by the fact that all the activity was 
recovered by trypsin-treatment (Fig. 3A) even after 2 h 
incubation. However, the same Fa = preparation conver- 
ted to E~ within 1 h when E. ct had been previously 
phosporylated with v-abl (Fig. 3C), as indicated by the 
recovery of the activity with trypsin and Mn 2÷. Incuba- 
tion involved some degree of irreve¢:;ible loss, ranging 
from 20-30% to over 50% in the case of free E., al- 
though free E. became more stable after v-abl phos- 
phorylation. The slight activation of isolated Ea ct by 
trypsin (Fig. 3B and D) is common and increases upon 
enzyme storage [18], In the literature there are conflic- 
ting reports of the E~ forms that are able to convert o 
Ei upon incubation with I2 [1,8-10,16,17], We confir- 
med that conversion could be obtained with Ea FA or  E,, ~ 
under the same conditions as in Fig, 3 (further described 
in [8,18]) but not in the case of E. c', although the 75% 
enzyme inhibition indicated that binding to I2 did take 
place, The fact that the E. ~' to E~ conversion became 
possible after phosphorylation by v-abl may indicate 
that phosphorylation i duces a conformational change 
that favours conversion, 
Altogether our results indicate an inverse relationship 
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between E, phosphorylation and inactivation in diluted 
conditions. The cytosolic E, forms and EaG, that are 
readily inactivated, are not phosphorylated to a signifi- 
cant degree, and this is not due to the presence of endo- 
genous phosphotyrosine. On the other hand the E,” 
form that is phosphorylated, does not convert readily 
to Ei until it has been phosphorylated. E,” and EaG 
might be different conformations or even different iso- 
zymes, whereas the difference among the cytosolic E, 
forms is more likely due to different conformations. 
One possibility is that early removal of 12 by ethanol 
during the purification induces or keeps Eaet in a con- 
formation that is different from the conformation of E 
that has been associated with I2 throughout the purifi- 
cation, and is finally obtained as Ei in the 70 kDa com- 
plex. It is not known at present whether PPI is a 
physiological substrate for v-abl or src kinase or other 
tyrosine kinases. The almost stoichiometric phospho- 
rylation, as well as the preference for one specific E, 
form, may be in favour of such an hypothesis. The 
absence of any effect on PPl activity following v-abl 
phosphorylation may be due to the use of an unsuitable 
substrate, or, alternatively, the function of such phos- 
phorylation might be in regulating the association with 
other molecules rather than on the activity. If such 
phosphorylation were taking place in vivo it would 
allow the introduction of a control by tyrosine kinases 
into pathways that are regulated by serine/threonine 
phosphorylation. Hence the physiological relevance of 
such a mechanism needs to be tested in cells expressing 
abl or src kinase or possibly other kinases of these same 
families. 
Ackr~o~c’/ed~e/,~rrlts; We wish to thank ~Mrs. G. Nigro for help in 
antibody production and purification and Dr. S. Lapi for help in 
clectrophoresis. This work was supported by grants from A.I.R.C. 
(Italian Cancer Association), Milan and M.U.R.S.T.. Rome. 
REFERENCES 
[I] Cohen, P. (1989) Annu. Rev. Biochem. 58. 453-508. 
[2] Cyert, MS. and Thomer. J. (1989) Cell 57, 891-893. 
[3] Chan, C.P., McNall, S.J., Krcbs, E.G. and Fischer, E.H. (i388) 
Proc. Nat]. Acad. Sci. USA 85, 6257-6261. 
[4] Olivier, A.R., Ballou, L.M. and Thomas, G. (1988) Proc. Natl. 
Acad. Sci. USA 85,4720-4724. 
[5] Villa-Moruzzi, E. (1989) FEBS Lett. 258. 208-210. 
[6] Yang, S-D., Chou, C.-K., Wuang, M., Song, J.-S. and Chen, 
H.-C. (1989) J. Biol. Chem. 264, 5407-5411. 
[7j Kinoshita, N., Ohkura, H. and Yanagida, M. (1990) Cell 63, 
405-415. 
[8] Villa-Moruzzi, E., Ballou, L.M. and Fischer. E.H. (1984) J. Biol. 
Chem. 259, 5857-5863. 
[9] Hemmings, B.A., Resink, T.J. and Cohen. P. (1982) FEBS Lett. 
150. 319-324. 
[IO] Jurgensen, S., Shatter. E., Huang, C., Chock, P.B., Yang, S.-D., 
Vandenheede. J.R. and Mcrlevede, W. (1984) J. Biol. Chem. 
5864-5871. 
[I l] DePaoli-Roach, A.A. (1984) J. Biol. Chem. 259. 121612152. 
[I21 Dent, P.. Lavoinne, A., Nakielny, S., Causwell, F.B., Watt, P. 
and Cohen, P. (1990) Nature 348, 302-308. 
[13] Johansen. J.W. and lngebritsen, T.S. (1986) Proc. Nat]. Acad. 
Sci. USA 83, 207-2 11. 
[14] Johansen, J.W. and Ingebritscn, T.S. (1987) Biochim. Biophys. 
Acta 928, 63-7.5. 
[15] Ingebritsen, T.S. and Johansen. J.W. (1985) Adv. Prote’n Phos- 
phatases I, 291-308. 
[I61 McNall, S., Ballou, L.M., Villa-Moruzzi, E. and Fischer, E.H. 
(1988) in: Methods in Enzymology, vol. 159 (Corbin, J.D. and 
Johnson, R.A. eds) pp. 377-390, Academic Press, San Diego. 
[I71 Resink, T.J., Hemmings, B.A.. Tung, H.Y.L. and Cohen, P. 
(1983) Eur. J. Biochem. 133, 455-461. 
[ 181 Villa-Moruzzi, E. (1986) Arch. Biochem. Biophys. 247, 155-164. 
[I91 Ferguson, B., Pritchard, M.L.. Feild. J., Reiman, D., Greig, 
R.G.. Poste, G. and Rosenberg, M. (1985) J. Biol. Chem. 260, 
3652-3657. 
[20] Wang, J.Y.J. and Baltimore. D. (1985) J. Biol. Chem. 260.6671. 
1211 Bradford. M.M. (19761 Anal. Biochcm. 72. 248-254. 
i22j Lacmmli,’ U.K. (i970)‘Nature 227, 680-685. 
[23] Cohen, P.T.W., Br wis, N-D., Hughes, V. and Mann. D.J. (1990) 
FEBS Lctt. 268. 355-359. 
[24J Merrifield, R.B. (1963) J. Am. Chem. Sot. 85, 2149-2154. 
[25] Tam, J.P.. Heart, W.F. and Merrifield, R.B. (1983) J. Am. Chem. 
Sot. 105. 6442-6451. 
[26] Villa-Moruzzi, E. and Crabb, J.W. (1989) Biochim. Biophys. Res. 
Commun l5? 146fm-1471 
[27] Towbin, H.,SyAehelin, T. and Gordon, J. (1979) Proc. Natl. Acad. 
Sci. USA 76. 4350-4354. 
